Cargando…
Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes
BACKGROUND: Engineered carbon nanotubes are currently used in many consumer and industrial products such as paints, sunscreens, cosmetics, toiletries, electronic processes and industrial lubricants. Carbon nanotubes are among the more widely used nanoparticles and come in two major commercial forms,...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895742/ https://www.ncbi.nlm.nih.gov/pubmed/24405760 http://dx.doi.org/10.1186/1743-8977-11-3 |
_version_ | 1782300004650582016 |
---|---|
author | Sargent, Linda M Porter, Dale W Staska, Lauren M Hubbs, Ann F Lowry, David T Battelli, Lori Siegrist, Katelyn J Kashon, Michael L Mercer, Robert R Bauer, Alison K Chen, Bean T Salisbury, Jeffrey L Frazer, David McKinney, Walter Andrew, Michael Tsuruoka, Shuji Endo, Morinobu Fluharty, Kara L Castranova, Vince Reynolds, Steven H |
author_facet | Sargent, Linda M Porter, Dale W Staska, Lauren M Hubbs, Ann F Lowry, David T Battelli, Lori Siegrist, Katelyn J Kashon, Michael L Mercer, Robert R Bauer, Alison K Chen, Bean T Salisbury, Jeffrey L Frazer, David McKinney, Walter Andrew, Michael Tsuruoka, Shuji Endo, Morinobu Fluharty, Kara L Castranova, Vince Reynolds, Steven H |
author_sort | Sargent, Linda M |
collection | PubMed |
description | BACKGROUND: Engineered carbon nanotubes are currently used in many consumer and industrial products such as paints, sunscreens, cosmetics, toiletries, electronic processes and industrial lubricants. Carbon nanotubes are among the more widely used nanoparticles and come in two major commercial forms, single-walled carbon nanotubes (SWCNT) and the more rigid, multi-walled carbon nanotubes (MWCNT). The low density and small size of these particles makes respiratory exposures likely. Many of the potential health hazards have not been investigated, including their potential for carcinogenicity. We, therefore, utilized a two stage initiation/promotion protocol to determine whether inhaled MWCNT act as a complete carcinogen and/or promote the growth of cells with existing DNA damage. Six week old, male, B6C3F1 mice received a single intraperitoneal (ip) injection of either the initiator methylcholanthrene(MCA, 10 μg/g BW, i.p.), or vehicle (corn oil). One week after i.p. injections, mice were exposed by inhalation to MWCNT (5 mg/m(3), 5 hours/day, 5 days/week) or filtered air (controls) for a total of 15 days. At 17 months post-exposure, mice were euthanized and examined for lung tumor formation. RESULTS: Twenty-three percent of the filtered air controls, 26.5% of the MWCNT-exposed, and 51.9% of the MCA-exposed mice, had lung bronchiolo-alveolar adenomas and lung adenocarcinomas. The average number of tumors per mouse was 0.25, 0.81 and 0.38 respectively. By contrast, 90.5% of the mice which received MCA followed by MWCNT had bronchiolo-alveolar adenomas and adenocarcinomas with an average of 2.9 tumors per mouse 17months after exposure. Indeed, 62% of the mice exposed to MCA followed by MWCNT had bronchiolo-alveolar adenocarcinomas compared to 13% of the mice that received filtered air, 22% of the MCA-exposed, or 14% of the MWCNT-exposed. Mice with early morbidity resulting in euthanasia had the highest rate of metastatic disease. Three mice exposed to both MCA and MWCNT that were euthanized early had lung adenocarcinoma with evidence of metastasis (5.5%). Five mice (9%) exposed to MCA and MWCNT and 1 (1.6%) exposed to MCA developed serosal tumors morphologically consistent with sarcomatous mesotheliomas, whereas mice administered MWCNT or air alone did not develop similar neoplasms. CONCLUSIONS: These data demonstrate that some MWCNT exposures promote the growth and neoplastic progression of initiated lung cells in B6C3F1 mice. In this study, the mouse MWCNT lung burden of 31.2 μg/mouse approximates feasible human occupational exposures. Therefore, the results of this study indicate that caution should be used to limit human exposures to MWCNT. |
format | Online Article Text |
id | pubmed-3895742 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38957422014-01-21 Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes Sargent, Linda M Porter, Dale W Staska, Lauren M Hubbs, Ann F Lowry, David T Battelli, Lori Siegrist, Katelyn J Kashon, Michael L Mercer, Robert R Bauer, Alison K Chen, Bean T Salisbury, Jeffrey L Frazer, David McKinney, Walter Andrew, Michael Tsuruoka, Shuji Endo, Morinobu Fluharty, Kara L Castranova, Vince Reynolds, Steven H Part Fibre Toxicol Research BACKGROUND: Engineered carbon nanotubes are currently used in many consumer and industrial products such as paints, sunscreens, cosmetics, toiletries, electronic processes and industrial lubricants. Carbon nanotubes are among the more widely used nanoparticles and come in two major commercial forms, single-walled carbon nanotubes (SWCNT) and the more rigid, multi-walled carbon nanotubes (MWCNT). The low density and small size of these particles makes respiratory exposures likely. Many of the potential health hazards have not been investigated, including their potential for carcinogenicity. We, therefore, utilized a two stage initiation/promotion protocol to determine whether inhaled MWCNT act as a complete carcinogen and/or promote the growth of cells with existing DNA damage. Six week old, male, B6C3F1 mice received a single intraperitoneal (ip) injection of either the initiator methylcholanthrene(MCA, 10 μg/g BW, i.p.), or vehicle (corn oil). One week after i.p. injections, mice were exposed by inhalation to MWCNT (5 mg/m(3), 5 hours/day, 5 days/week) or filtered air (controls) for a total of 15 days. At 17 months post-exposure, mice were euthanized and examined for lung tumor formation. RESULTS: Twenty-three percent of the filtered air controls, 26.5% of the MWCNT-exposed, and 51.9% of the MCA-exposed mice, had lung bronchiolo-alveolar adenomas and lung adenocarcinomas. The average number of tumors per mouse was 0.25, 0.81 and 0.38 respectively. By contrast, 90.5% of the mice which received MCA followed by MWCNT had bronchiolo-alveolar adenomas and adenocarcinomas with an average of 2.9 tumors per mouse 17months after exposure. Indeed, 62% of the mice exposed to MCA followed by MWCNT had bronchiolo-alveolar adenocarcinomas compared to 13% of the mice that received filtered air, 22% of the MCA-exposed, or 14% of the MWCNT-exposed. Mice with early morbidity resulting in euthanasia had the highest rate of metastatic disease. Three mice exposed to both MCA and MWCNT that were euthanized early had lung adenocarcinoma with evidence of metastasis (5.5%). Five mice (9%) exposed to MCA and MWCNT and 1 (1.6%) exposed to MCA developed serosal tumors morphologically consistent with sarcomatous mesotheliomas, whereas mice administered MWCNT or air alone did not develop similar neoplasms. CONCLUSIONS: These data demonstrate that some MWCNT exposures promote the growth and neoplastic progression of initiated lung cells in B6C3F1 mice. In this study, the mouse MWCNT lung burden of 31.2 μg/mouse approximates feasible human occupational exposures. Therefore, the results of this study indicate that caution should be used to limit human exposures to MWCNT. BioMed Central 2014-01-09 /pmc/articles/PMC3895742/ /pubmed/24405760 http://dx.doi.org/10.1186/1743-8977-11-3 Text en Copyright © 2014 Sargent et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Sargent, Linda M Porter, Dale W Staska, Lauren M Hubbs, Ann F Lowry, David T Battelli, Lori Siegrist, Katelyn J Kashon, Michael L Mercer, Robert R Bauer, Alison K Chen, Bean T Salisbury, Jeffrey L Frazer, David McKinney, Walter Andrew, Michael Tsuruoka, Shuji Endo, Morinobu Fluharty, Kara L Castranova, Vince Reynolds, Steven H Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes |
title | Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes |
title_full | Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes |
title_fullStr | Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes |
title_full_unstemmed | Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes |
title_short | Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes |
title_sort | promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895742/ https://www.ncbi.nlm.nih.gov/pubmed/24405760 http://dx.doi.org/10.1186/1743-8977-11-3 |
work_keys_str_mv | AT sargentlindam promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT porterdalew promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT staskalaurenm promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT hubbsannf promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT lowrydavidt promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT battellilori promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT siegristkatelynj promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT kashonmichaell promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT mercerrobertr promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT baueralisonk promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT chenbeant promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT salisburyjeffreyl promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT frazerdavid promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT mckinneywalter promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT andrewmichael promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT tsuruokashuji promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT endomorinobu promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT fluhartykaral promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT castranovavince promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes AT reynoldsstevenh promotionoflungadenocarcinomafollowinginhalationexposuretomultiwalledcarbonnanotubes |